BioCentury
ARTICLE | Company News

ImmuneRegen, Azopharma Product Development Group deal

September 28, 2009 7:00 AM UTC

The companies signed a letter of intent for CRO Azopharma to perform manufacturing, formulation development, preclinical toxicology and pharmacology studies of ImmuneRegen's Homspera. The analog of t...